Desktop Site |
24 Apr 24 | 14:18 | Open
Equity SME Eq Drv Currency Commodity Corporates
Get Quote
Notices |
S&P BSE SENSEX 74,007.01 +268.56 +0.36 %
Corporate Announcement
  • Security Code532296
    CompanyGlenmark Pharmaceuticals Ltd
    Exchange Received Time01/03/2018 17:13:17
    Exchange Disseminated Time01/03/2018 17:13:21
    Time Taken00:00:04
     
     
     Announcement under Regulation 30 (LODR)-Credit Rating | 03/01/18 17:13 
     Sub:- Rating by S&P Global Ratings

    With reference to the above subject, we have to inform you that our credit rating has been revised by S&P Global Ratings from 'BB' to 'BB-' as part of their review cycle. They have revised the outlook from 'Negative' to 'Stable'.

    In addition, they have revised the rating on the senior unsecured notes issued in 2016 from 'BB' to 'BB-'.

    Kindly find enclosed rating research update issued by S&P Global for your reference.
    		 
    AttachmentDownload PDF
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(122H) 24 Apr 24|14:18 (IST)